Truist Financial Corp Illumina, Inc. Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Illumina, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 53,714 shares of ILMN stock, worth $7.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

53,714

Previous 62,840 14.52%

Holding current value

$7.53 Million

Previous $6.56 Million 6.78%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$105.28 - $135.9 $960,785 - $1.24 Million	-9,126 Reduced 14.52%	53,714 $7 Million
Q2 2024 Aug 20, 2024	BUY	$101.05 - $133.57 $108,628 - $143,587	1,075 Added 1.74%	62,840 $6.56 Million
Q1 2024 May 10, 2024	BUY	$127.73 - $147.2 $212,542 - $244,940	1,664 Added 2.77%	61,765 $8.48 Million
Q4 2023 Feb 02, 2024	BUY	$92.79 - $142.53 $228,448 - $350,908	2,462 Added 4.27%	60,101 $8.37 Million
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $316,602 - $472,632	2,456 Added 4.45%	57,639 $7.91 Million
Q2 2023 Aug 01, 2023	BUY	$183.43 - $232.67 $967,226 - $1.23 Million	5,273 Added 10.57%	55,183 $10.3 Million
Q1 2023 May 05, 2023	BUY	$193.75 - $232.55 $888,150 - $1.07 Million	4,584 Added 10.11%	49,910 $11.6 Million
Q4 2022 Feb 17, 2023	SELL	$187.24 - $242.74 $894,071 - $1.16 Million	-4,775 Reduced 9.53%	45,326 $9.16 Million
Q3 2022 Oct 26, 2022	BUY	$177.23 - $227.44 $54,941 - $70,506	310 Added 0.62%	50,101 $9.56 Million
Q2 2022 Jul 22, 2022	SELL	$181.58 - $368.0 $32,865 - $66,608	-181 Reduced 0.36%	49,791 $9.18 Million
Q1 2022 Apr 22, 2022	BUY	$303.87 - $423.8 $789,454 - $1.1 Million	2,598 Added 5.48%	49,972 $17.5 Million
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $117,033 - $142,156	-337 Reduced 0.71%	47,374 $18 Million
Q3 2021 Nov 05, 2021	BUY	$405.61 - $524.84 $382,084 - $494,399	942 Added 2.01%	47,711 $19.4 Million
Q2 2021 Aug 16, 2021	BUY	$372.84 - $481.5 $341,894 - $441,535	917 Added 2.0%	46,769 $22.1 Million
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $1.06 Million - $1.49 Million	2,946 Added 6.87%	45,852 $17.6 Million
Q4 2020 Feb 18, 2021	BUY	$292.7 - $370.96 $2.84 Million - $3.6 Million	9,697 Added 29.2%	42,906 $15.9 Million
Q3 2020 Nov 05, 2021	BUY	$268.51 - $400.74 $4,833 - $7,213	18 Added 0.05%	33,209 $10.3 Million
Q3 2020 Nov 13, 2020	SELL	$268.51 - $400.74 $625,359 - $933,323	-2,329 Reduced 6.56%	33,191 $10.3 Million
Q2 2020 Nov 16, 2021	BUY	$256.46 - $373.01 $4,616 - $6,714	18 Added 0.05%	35,520 $13.2 Million
Q2 2020 Aug 14, 2020	BUY	$256.46 - $373.01 $4.41 Million - $6.41 Million	17,190 Added 93.87%	35,502 $13.1 Million
Q1 2020 Nov 05, 2021	BUY	$209.2 - $335.53 $3,765 - $6,039	18 Added 0.1%	18,312 $5 Million
Q1 2020 May 15, 2020	SELL	$209.2 - $335.53 $498,314 - $799,232	-2,382 Reduced 11.52%	18,294 $5 Million
Q4 2019 Nov 16, 2021	BUY	$288.29 - $335.49 $5,189 - $6,038	18 Added 0.09%	20,676 $6.86 Million
Q4 2019 Feb 14, 2020	BUY	$288.29 - $335.49 $5.11 Million - $5.95 Million	17,731 Added 605.77%	20,658 $6.85 Million
Q3 2019 Oct 31, 2019	SELL	$266.84 - $378.23 $94,728 - $134,271	-355 Reduced 10.82%	2,927 $890,000
Q2 2019 Jul 24, 2019	SELL	$300.59 - $368.15 $41,782 - $51,172	-139 Reduced 4.06%	3,282 $1.21 Million
Q1 2019 Apr 23, 2019	BUY	$272.57 - $321.18 $75,229 - $88,645	276 Added 8.78%	3,421 $1.06 Million
Q4 2018 Jan 22, 2019	BUY	$272.46 - $366.54 $199,168 - $267,940	731 Added 30.28%	3,145 $943,000
Q3 2018 Oct 17, 2018	BUY	$279.04 - $367.06 $260,902 - $343,201	935 Added 63.22%	2,414 $886,000
Q2 2018 Jul 26, 2018	BUY	$228.17 - $292.07 $87,845 - $112,446	385 Added 35.19%	1,479 $413,000
Q1 2018 Apr 20, 2018	BUY	$209.54 - $253.91 $229,236 - $277,777	1,094 New	1,094 $258,000

Others Institutions Holding ILMN

# of Institutions

899

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Illumina, Inc. Transaction History